Pasithea Therapeutics (KTTA) Prepaid Assets (2020 - 2026)
Pasithea Therapeutics recorded quarterly Prepaid Assets of $1.8 million in Q1 2026, up 371.74% quarter-over-quarter from $387823.0 in Q4 2025, and up 1026.18% year-over-year from $162454.0 in Q1 2025.
Pasithea Therapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $1.8 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 1026.18% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (up 1026.18% YoY), while the FY2025 annual figure was $387823.0, up 28.15% from the prior year.
- Prepaid Assets came in at $1.8 million for Q1 2026 at Pasithea Therapeutics, up from $387823.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.8 million in Q1 2026 to a low of $19665.0 in Q3 2025.
- A 5-year average of $455943.3 and a median of $302641.0 in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets plunged 95.41% in 2023 and surged 3494.7% in 2024, its largest moves.
- Pasithea Therapeutics' Prepaid Assets stood at $262992.0 in 2022, then decreased by 17.91% to $215895.0 in 2023, then surged by 40.18% to $302641.0 in 2024, then increased by 28.15% to $387823.0 in 2025, then jumped by 371.74% to $1.8 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $1.8 million, $387823.0, and $19665.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Pasithea Therapeutics | 17.41 Mn | 17.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.83 Mn |
| Dec 31, 2025 | 811,456.00 |
| Sep 30, 2025 | 19,665.00 |
| Jun 30, 2025 | 117,842.00 |
| Mar 31, 2025 | 162,454.00 |
| Dec 31, 2024 | 302,641.00 |
| Sep 30, 2024 | 98,333.00 |
| Jun 30, 2024 | 570,242.00 |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 104,707.00 |
| Sep 30, 2023 | 985,067.00 |
| Jun 30, 2023 | 452,195.00 |
| Mar 31, 2023 | 835,777.00 |
| Dec 31, 2022 | 262,992.00 |
| Sep 30, 2022 | 865,985.00 |
| Jun 30, 2022 | 79,595.00 |
| Mar 31, 2022 | 628,740.00 |
| Dec 31, 2021 | 333,751.00 |
| Sep 30, 2021 | 468,527.00 |
| Dec 31, 2020 | 4,308.00 |